Literature DB >> 28476483

Cancer incidence and mortality in China, 2013.

Wanqing Chen1, Rongshou Zheng2, Siwei Zhang2, Hongmei Zeng2, Changfa Xia2, Tingting Zuo2, Zhixun Yang2, Xiaonong Zou2, Jie He3.   

Abstract

OBJECTIVE: National Central Cancer Registry of China (NCCRC) updated nationwide statistics of cancer incidence and mortality in China using population-based cancer registration data in 2013 from all available cancer registries.
METHODS: In 2016, 255 registries' data were qualified and included in this analysis. We estimated numbers of new cancer cases and deaths in China in 2013 using age-specific rates and corresponding national population stratified by area, sex, age group (0, 1-4, 5-9, 10-14…85+) and cancer type. The world Segi's population was applied for age-standardized rates. All rates were expressed per 100,000 person-year.
RESULTS: A total of 3,682,000 new cancer cases and 2,229,300 cancer deaths were estimated in China in 2013. Cancers of lung, female breast, stomach, liver, colon-rectum and esophagus were the most common cancers, accounting for about half of all cancer new cases. Lung cancer, liver cancer, stomach cancer, esophageal cancer, colorectal cancer were the five leading causes of cancer death, accounting for about 60% of all cancer deaths. The cancer patterns showed differences not only between male and female, but also among different geographic regions in China. For overall cancers, the age-standardized incidence rates were stable during the past decades in male, but significantly increased by 2.2% per year in female.
CONCLUSIONS: Cancer poses a major threat to public health and the cancer burden keep raising in China. The annual updated cancer statistics can provide scientific basis for cancer prevention and control.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer registry; China; Epidemiology; Incidence; Mortality

Mesh:

Year:  2017        PMID: 28476483     DOI: 10.1016/j.canlet.2017.04.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  153 in total

1.  MiR-514a-3p inhibits cell proliferation and epithelial-mesenchymal transition by targeting EGFR in clear cell renal cell carcinoma.

Authors:  Xinwen Ke; Xing Zeng; Xian Wei; Yuanqing Shen; Jiahua Gan; Huake Tang; Zhiquan Hu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Genetic variations associated with telomere length confer risk of gastric cardia adenocarcinoma.

Authors:  Nasha Zhang; Yan Zheng; Jie Liu; Tiansui Lei; Yeyang Xu; Ming Yang
Journal:  Gastric Cancer       Date:  2019-03-21       Impact factor: 7.370

3.  Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma.

Authors:  Yu-Zhen Yin; Shi-Hua Yao; Chun-Guang Li; Yu-Shui Ma; Zhou-Jun Kang; Jia-Jia Zhang; Cheng-You Jia; Li-Kun Hou; Shan-Shan Qin; Xin Fan; Han Zhang; Meng-Die Yang; Dan-Dan Zhang; Gai-Xia Lu; Hui-Min Wang; Li-Peng Gu; Lin-Lin Tian; Pei-Yao Wang; Ping-Sheng Cao; Wei Wu; Zi-Yang Cao; Zhong-Wei Lv; Bo-Wen Shi; Chun-Yan Wu; Geng-Xi Jiang; Da Fu; Fei Yu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

4.  Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer.

Authors:  Sicheng Lu; Mengjie Guo; Zhimin Fan; Ying Chen; Xuqin Shi; Chunyan Gu; Ye Yang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

5.  FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival.

Authors:  Mengjie Wu; Yongfeng Ding; Nan Wu; Junjie Jiang; Yingying Huang; Fanyu Zhang; Haiyong Wang; Quan Zhou; Yan Yang; Wei Zhuo; Lisong Teng
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

6.  Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study.

Authors:  Liting Xi; Jinzhou Zhu; Huixian Zhang; Merlin Muktiali; Chunfang Xu; Airong Wu
Journal:  Dig Dis Sci       Date:  2018-10-22       Impact factor: 3.199

Review 7.  Current status and progress of lymphoma management in China.

Authors:  Yuankai Shi
Journal:  Int J Hematol       Date:  2018-01-31       Impact factor: 2.490

8.  The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.

Authors:  L-F Wang; Y-S Liu; B Yang; P Li; X-S Cheng; C-X Xiao; J-J Liu; S Li; J-L Ren; B Guleng
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

9.  Robotic-assisted Laparoscopic Nephrectomy with Vein Thrombectomy: Initial Experience and Outcomes from a Single Surgeon.

Authors:  Xin-Wen Ke; Xing Zeng; Xian Wei; Yuan-Qing Shen; Jia-Hua Gan; Ji-Hua Tian; Zhi-Quan Hu
Journal:  Curr Med Sci       Date:  2018-10-20

Review 10.  The role of MRI in the diagnosis and treatment of gastric cancer.

Authors:  Yingjing Zhang; Jianchun Yu
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.